1496
P. Appukkuttan et al.
LETTER
(12) 3-Benzyl-5-chloro-1-(4-methoxybenzyl)-2(1H)-
pyrazinone (3a).
10 H), 7.49 (d, 2 H, J = 8.29 Hz) ppm. 13C NMR (75 MHz,
CDCl3): d = 39.8, 55.3, 114.0, 125.6, 128.2, 128.7, 129.0,
129.2, 130.0, 130.8, 131.3, 136.4, 137.2, 155.1, 158.3, 159.5
ppm. MS (CI): m/z (%) = 403 (100) [MH+]. HRMS (EI):
m/z calcd for C24H19N2ClO2: 402.1135; found: 402.1142.
5-Chloro-3-(4-methoxybenzyl)-1-(3-phenylpropyl)-
2(1H)-pyrazinone (3h).
Mp 102–103 °C. 1H NMR (300 MHz, CDCl3): d = 3.8 (s, 3
H), 4.12 (s, 2 H), 4.93 (s, 2 H), 6.9 (d, 2 H, J = 8.7 Hz), 7.01
(s, 1 H), 7.30–7.35 (m, 5 H), 7.44 (d, 2 H, J = 7.0 Hz) ppm.
13C NMR (75 MHz, CDCl3): d = 39.8, 51.8, 55.2, 114.4,
124.3, 125.7, 125.8, 126.5, 128.3, 129.3, 130.2, 136.3,
154.4, 158.8, 159.8 ppm. MS (CI): m/z (%) = 341 [MH+],
121 (100). HRMS (EI): m/z calcd for C19H17N2ClO2:
340.0978; found: 340.0972.
Mp 113–114 °C. 1H NMR (300 MHz, CDCl3): d = 2.03–2.08
(m, 2 H), 2.66 (t, J = 7.32 Hz, 2 H), 3.75 (s, 3 H), 3.82 (t,
J = 7.32 Hz, 2 H), 4.03 (s, 2 H), 6.83 (d, J = 8.22 Hz, 2 H),
6.99 (s, 1 H), 7.14 (d, J = 6.39 Hz, 2 H), 7.19–7.28 (m, 5 H)
ppm. 13C NMR (75 MHz, CDCl3): d = 29.7, 32.7, 39.1, 49.8,
55.2, 113.9, 125.2, 125.7, 126.7, 128.2, 128.5, 128.6, 130.5,
140.0, 154.6, 158.5, 159.2 ppm. MS (CI): m/z = 369 (100)
[MH+]. HRMS (EI): m/z calcd for C21H21N2ClO2: 368.1291;
found: 368.1287.
3-Benzyl-5-chloro-(3-phenylpropyl)-2(1H)-pyrazinone
(3b).
Mp 98–100 °C. 1H NMR (300 MHz, CDCl3): d = 2.03–2.19
(m, 2 H), 2.68 (t, J = 7.35 Hz, 2 H), 3.84 (t, J = 7.35 Hz, 2
H), 4.12 (s, 2 H), 6.92 (s, 1 H, C-6H), 7.15–7.44 (m, 10 H)
ppm. 13C NMR (75 MHz, CDCl3): d = 29.6, 32.7, 39.9, 49.8,
125.3, 125.6, 126.3, 126.7, 128.2, 128.3, 128.4, 128.6,
136.0, 139.0, 154.5, 158.9 ppm. MS (CI): m/z (%) = 339
(100) [MH+]. HRMS (EI): m/z calcd for C20H19N2ClO:
338.1185; found: 338.1194.
5-Chloro-1-(3-phenylpropyl)-3-(3,4,5-trimethoxy-
benzyl)-2(1H)-pyrazinone (3i).
Mp 104–105 °C. 1H NMR (300 MHz, CDCl3): d = 2.05–2.10
(m, 2 H), 2.67 (t, J = 7.44 Hz, 2 H), 3.80–3.88 (m, 11 H),
4.03 (s, 2 H), 6.67 (s, 2 H), 7.02 (s, 1 H), 7.15–7.30 (m, 5 H)
ppm. 13C NMR (75 MHz, CDCl3): d = 29.8, 32.8, 40.1, 50.0,
56.2, 56.3, 55.4, 106.5, 125.5, 125.7, 126.5, 128.3, 128.7,
132.3, 136.8, 140.0, 153.2, 153.3, 154.7, 158.7 ppm. MS
(CI): m/z (%) = 429 (100) [MH+]. HRMS (EI): m/z calcd for
C23H25N2ClO4: 428.1502; found: 428.1499.
3-Benzyl-5-chloro-1-cyclohexylmethyl-2(1H)-
pyrazinone (3c).
Mp 107–108 °C. 1H NMR (300 MHz, CDCl3): d = 1.13–1.90
(m, 11 H), 3.78 (d, J = 7.41 Hz, 2 H), 4.10 (s, 2 H), 7.21 (s,
1 H), 7.12–7.18 (m, 3 H), 7.32 (d, J = 7.32 Hz, 2 H) ppm. 13
NMR (75 MHz, CDCl3): d = 25.5, 26.1, 30.6, 36.8, 40.2,
C
57.4, 122.4, 126.2, 126.7, 128.4, 129.3, 136.5, 154.1, 158.7
ppm. MS (CI): m/z (%) = 317 (100) [MH+]. HRMS (EI):
m/z calcd for C18H21N2ClO: 316.1342; found: 316.1344.
3-Benzyl-5-chloro-1-cyclohexyl-2(1H)-pyrazinone (3d).
Mp 139–140 °C. 1H NMR (300 MHz, CDCl3): d = 1.37–1.91
(m, 10 H), 4.10 (s, 2 H), 4.68–4.76 (m, 1 H), 7.12 (s, 1 H),
5-Chloro-3-(2-fluorobenzyl)-1-(3-phenylpropyl)-2(1H)-
pyrazinone (3j).
Mp 97–98 °C. 1H NMR (300 MHz, CDCl3): d = 2.03–2.13
(m, 2 H), 2.67 (t, J = 7.40 Hz, 2 H), 3.85 (t, J = 7.47 Hz, 2
H), 4.15 (s, 2 H), 7.01 (s, 1 H), 7.02–7.31 (m, 9 H) ppm. 13
C
NMR (75 MHz, CDCl3): d = 29.8, 32.8, 33.2, 49.9, 115.6,
124.0, 125.5, 125.8, 126.5, 128.3, 128.5, 128.7, 131.5,
131.6, 140.1, 154.5, 158.7, 162.9 ppm. MS (CI): m/z (%) =
357 (100) [MH+]. HRMS (EI): m/z calcd for C20H18N2FClO:
356.1092; found: 356.1098.
7.18–7.30 (m, 3 H), 7.41 (d, J = 7.32 Hz, 2 H) ppm. 13
C
NMR (75 MHz, CDCl3): d = 25.2, 25.6, 30.0, 40.3, 55.5,
121.8, 126.2, 126.7, 128.5, 129.6, 136.7, 154.2, 158.6 ppm.
MS (CI): m/z 303 (100) [MH+]. HRMS (EI): m/z calcd for
C17H19N2ClO: 302.1185; found: 302.1184.
3-Allyl-5-chloro-1-(3-phenylpropyl)-2(1H)-pyrazinone
(3m).
3-Benzyl-5-chloro-1,6-diphenyl-2(1H)-pyrazinone (3f).
Mp 180–181 °C. 1H NMR (300 MHz, CDCl3): d = 4.12 (s, 2
H), 6.96–7.84 (m, 15 H) ppm. 13C NMR (75 MHz, CDCl3):
d = 40.2, 125.6, 126.87, 128.2, 128.2, 28.6, 128.7, 129.0,
129.1, 129.8, 130.0, 130.7, 131.2, 136.7, 137.2, 155.5, 158.3
ppm. MS (CI): m/z (%) = 373 (100) [MH+]. HRMS (EI):
m/z calcd for C23H17N2ClO: 372.1029; found: 372.1020.
5-Chloro-3-(4-methoxybenzyl)-1,6-diphenyl-2(1H)-
pyrazinone (3g).
Viscous oil. 1H NMR (300 MHz, CDCl3): d = 2.05–2.13 (m,
2 H), 2.22 (dd, J = 1.83, 5.49 Hz, 2 H), 2.71 (t, J = 7.34 Hz,
2 H), 3.89 (t, J = 7.30 Hz, 2 H), 6.83 (dd, J = 1.88, 14.16 Hz,
2 H), 6.99 (s, 1 H), 7.17–7.33 (m, 6 H) ppm. 13C NMR (75
MHz, CDCl3): d = 30.1, 31.9, 33.1, 50.2, 124.6, 124.5,
125.8, 126.8, 128.6, 129.1, 139.3, 140.5, 152.3, 154.7 ppm.
MS (CI): m/z (%) = 289 (100) [MH+]. HRMS (EI): m/z calcd
for C16H17N2ClO: 288.1029; found: 288.1034. Anal. Calcd
for C16H17N2ClO: C, 66.55; H, 5.93; N, 9.70. Found: C,
66.60; H, 5.97; N, 9.68.
Mp 194–195° °C. 1H NMR (300 MHz, CDCl3): d = 3.80 (s,
3 H), 4.16 (s, 2 H,), 6.89 (d, 2 H, J = 8.47 Hz), 6.96–7.29 (m,
Synlett 2006, No. 10, 1491–1496 © Thieme Stuttgart · New York